Gerasimos S Filippatos Selected Research

Gerasimos S Filippatos Research Topics

Disease

59	Heart Failure 12/2023 - 06/2004
8	Dyspnea (Shortness of Breath) 03/2016 - 05/2010
5	Left Ventricular Dysfunction 10/2019 - 05/2008
4	Type 2 Diabetes Mellitus (MODY) 10/2022 - 10/2019
4	Iron Deficiencies 01/2022 - 01/2013
4	Atrial Fibrillation 10/2021 - 05/2010
3	Systolic Heart Failure 01/2014 - 11/2012
3	Cachexia 06/2008 - 07/2003
2	Mitral Valve Insufficiency (Mitral Regurgitation) 12/2023 - 08/2022
2	Pneumonia (Pneumonitis) 10/2022 - 03/2012
2	Chronic Renal Insufficiency 10/2022 - 10/2021
2	Necrosis 01/2020 - 05/2008
2	Inflammation (Inflammations) 10/2019 - 05/2010
2	Fibrosis (Cirrhosis) 10/2019 - 07/2003
2	Cardiomyopathies (Cardiomyopathy) 01/2019 - 01/2013
2	Heart Diseases (Heart Disease) 11/2017 - 11/2007
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 03/2017 - 04/2007
2	Critical Illness (Critically Ill) 05/2011 - 01/2006
2	Hyperuricemia 10/2010 - 09/2007
2	Hypertension (High Blood Pressure) 05/2010 - 04/2002
2	Torsades de Pointes (Torsade de Pointes) 04/2009 - 01/2006
1	COVID-19 10/2022
1	Neoplasms (Cancer) 01/2021
1	Disease Progression 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2020
1	Hypertrophy 01/2020
1	Myocardial Infarction 11/2012
1	Obesity 09/2012
1	Renal Insufficiency (Renal Failure) 09/2012
1	Bacterial Infections (Bacterial Infection) 03/2012
1	Hyperinsulinism (Hyperinsulinemia) 10/2010
1	Heart Arrest (Cardiac Arrest) 04/2009
1	Pulmonary Edema 11/2008

Drug/Important Bio-Agent (IBA)

16	Biomarkers (Surrogate Marker)IBA 12/2023 - 09/2007
9	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2021 - 06/2004
6	Atrial Natriuretic Factor (ANF)IBA 09/2016 - 11/2007
5	pro-brain natriuretic peptide (1-76)IBA 10/2021 - 09/2007
5	Natriuretic PeptidesIBA 09/2016 - 09/2008
4	Glucose (Dextrose)FDA LinkGeneric 11/2020 - 10/2019
4	SodiumIBA 11/2020 - 10/2019
4	Sodium-Glucose Transporter 2 InhibitorsIBA 11/2020 - 10/2019
4	empagliflozinIBA 11/2020 - 10/2019
4	SymportersIBA 11/2020 - 10/2019
4	AdrenomedullinIBA 09/2012 - 05/2010
4	IstaroximeIBA 12/2009 - 05/2008
3	ferric carboxymaltoseIBA 01/2022 - 01/2013
3	dapagliflozinIBA 11/2020 - 10/2019
3	CanagliflozinIBA 11/2020 - 10/2019
3	Digoxin (Digitek)FDA LinkGeneric 01/2014 - 01/2009
3	Uric Acid (Urate)IBA 10/2010 - 09/2007
2	Mineralocorticoid Receptor AntagonistsIBA 10/2022 - 11/2012
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 01/2018
2	ProcalcitoninIBA 01/2019 - 03/2012
2	salicylhydroxamic acid (SHAM)IBA 11/2017 - 03/2017
2	Dobutamine FDA LinkGeneric 03/2009 - 07/2006
2	Simendan (Levosimendan)IBA 03/2009 - 07/2006
1	Indicators and Reagents (Reagents)IBA 11/2023
1	Sulfhydryl Compounds (Thiols)IBA 08/2023
1	finerenoneIBA 10/2022
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 10/2022
1	AlbuminsIBA 10/2022
1	CreatineIBA 10/2022
1	IronIBA 01/2022
1	ertugliflozinIBA 11/2020
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2020
1	Angiotensin Receptor AntagonistsIBA 01/2020
1	Aryldialkylphosphatase (Paraoxonase)IBA 01/2020
1	P-SelectinIBA 01/2020
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2020
1	DiureticsIBA 10/2019
1	Blood Glucose (Blood Sugar)IBA 10/2019
1	HepcidinsIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2018
1	Enalapril FDA LinkGeneric 01/2018
1	CreatinineIBA 09/2016
1	Cardiac MyosinsIBA 03/2016
1	omecamtiv mecarbilIBA 03/2016
1	Peptides (Polypeptides)IBA 06/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2012
1	Arginine Vasopressin (Argipressin)IBA 09/2011
1	TroponinIBA 08/2011
1	proadrenomedullinIBA 08/2011
1	Endothelin-1 (Endothelin 1)IBA 01/2011
1	Insulin (Novolin)FDA Link 10/2010
1	Hormones (Hormone)IBA 05/2010
1	C-Reactive ProteinIBA 05/2010
1	Adenosine Triphosphatases (ATPase)IBA 12/2009
1	Antidiuretic Hormone Receptor AntagonistsIBA 01/2009

Therapy/Procedure

23	Therapeutics 11/2022 - 09/2007
2	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2023 - 03/2017
2	Critical Care (Surgical Intensive Care) 01/2018 - 08/2005
2	Patient Readmission 01/2014 - 08/2013
2	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 10/2007 - 04/2007
1	Duration of Therapy 10/2022
1	Aftercare (After-Treatment) 10/2022
1	Injections 12/2020
1	Biological Therapy 03/2017
1	Intravenous Infusions 03/2016
1	Resuscitation 04/2009